<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We studied the serum <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> profiles in 44 patients with <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:hpo ids='HP_0003584'>late-onset</z:hpo> Alzheimer's <z:hpo ids='HP_0000726'>dementia</z:hpo> and 43 patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The levels of <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>) cholesterol were lower in both patient groups than in a control group </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="39015">Apolipoprotein</z:chebi> A I and A II levels have decreased in both the patient groups, especially in the vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> group </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> levels correlated positively with the level of <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A I, but not with the level of <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A II </plain></SENT>
<SENT sid="4" pm="."><plain>The ratios of <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A I/A II have increased in both the patient groups </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A II levels have disproportionally decreased in the patient groups </plain></SENT>
<SENT sid="6" pm="."><plain>The serum <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A II may involve the <z:mpath ids='MPATH_596'>pathological process</z:mpath> in the patients with senile <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>